menu
search more_vert
Home / Extracorporeal Membrane Oxygenation System Market

Global Extracorporeal Membrane Oxygenation System Market By Type (Veno-Arterial (VA) , Veno-Venous (VV) , and Arterio-Venous (AV)), By Application (Respiratory , Cardiac , and Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • account_circleAbout Me
    • 62796
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now

    Global Extracorporeal Membrane Oxygenation System Market is estimated to be valued US$ XX.X million in 2019. The report on Extracorporeal Membrane Oxygenation System Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global extracorporeal membrane oxygenation system market is segmented on the basis of type, application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Global Extracorporeal Membrane Oxygenation System Market

    By type, the market is segmented into Veno-Arterial (VA), Veno-Venous (VV), and Arterio-Venous (AV). By application, the market is divided into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR).

    Request Covid - 19 Impact

    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, ALung Technologies, and EUROSETS S.r.l..

    Key Market Segments

    Type

    • Veno-Arterial (VA)
    • Veno-Venous (VV)
    • Arterio-Venous (AV)

    Application

    • Respiratory
    • Cardiac
    • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

    Key Market Players included in the report:

    • Getinge Group
    • Medtronic plc
    • LivaNova PLC
    • XENIOS AG
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • NIPRO Corporation
    • OriGen Biomedical
    • ALung Technologies
    • EUROSETS S.r.l.

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Extracorporeal Membrane Oxygenation System Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Extracorporeal Membrane Oxygenation System Market; high-growth regions; and market drivers, restraints, and also market chances.

    The analysis covers Extracorporeal Membrane Oxygenation System Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Extracorporeal Membrane Oxygenation System Market across sections such as also application and representatives.

    Additionally, the analysis also has a comprehensive review of the crucial players on the Extracorporeal Membrane Oxygenation System Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    • To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    • To know the Extracorporeal Membrane Oxygenation System Market by pinpointing its many subsegments.
    • To profile the important players and analyze their growth plans.
    • To endeavor the amount and value of Extracorporeal Membrane Oxygenation System sub-markets, depending on key regions (various vital states).
    • To analyze Extracorporeal Membrane Oxygenation System Market concerning growth trends, prospects, and also their participation in the entire sector.
    • To examine and study the Extracorporeal Membrane Oxygenation System Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2013 to 2018, and also prediction to 2029.
    • Primary worldwide Extracorporeal Membrane Oxygenation System Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    • To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

    For the Extracorporeal Membrane Oxygenation System Market research study, the following years have been considered to estimate the market size:

    Particular Scope
    Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East and Africa

    Historic Year 2016 to 2020
    Base Year 2021
    Estimated Year 2022
    Forecast Year 2023 to 2032

    Extracorporeal Membrane Oxygenation System Market

    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
    • 62796
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
    • 1. Extracorporeal Membrane Oxygenation System Market Introduction
      • 1.1. Definition
      • 1.2. Taxonomy
      • 1.3. Research Scope
    • 2. Executive Summary
      • 2.1. Key Findings by Major Segments
      • 2.2. Top strategies by Major Players
    • 3. Global Extracorporeal Membrane Oxygenation System Market Overview
      • 3.1. Extracorporeal Membrane Oxygenation System Market Dynamics
        • 3.1.1. Drivers
        • 3.1.2. Opportunities
        • 3.1.3. Restraints
        • 3.1.4. Challenges
      • 3.2. PESTLE Analysis
      • 3.3. Opportunity Map Analysis
      • 3.4. PORTER'S Five Forces Analysis
      • 3.5. Market Competition Scenario Analysis
      • 3.6. Product Life Cycle Analysis
      • 3.7. Opportunity Orbits
      • 3.8. Production Analysis by Region/Company
      • 3.9. Industry chain Analysis
      • 3.10. Marketing Strategy
    • 4. Global Extracorporeal Membrane Oxygenation System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
      • 4.1. Global Extracorporeal Membrane Oxygenation System Market Analysis by Type: Introduction
      • 4.2. Market Size and Forecast by Region
      • 4.3. Veno-Arterial (VA)
      • 4.4. Veno-Venous (VV)
      • 4.5. Arterio-Venous (AV)
    • 5. Global Extracorporeal Membrane Oxygenation System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
      • 5.1. Global Extracorporeal Membrane Oxygenation System Market Analysis by Application: Introduction
      • 5.2. Market Size and Forecast by Region
      • 5.3. Respiratory
      • 5.4. Cardiac
      • 5.5. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
    • 6. Global Extracorporeal Membrane Oxygenation System Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
      • 6.1. North America
        • 6.1.1. North America Extracorporeal Membrane Oxygenation System Market: Regional Trend Analysis
          • 6.1.1.1. US
          • 6.1.1.2. Canada
          • 6.1.1.3. Mexico
      • 6.2.1. Europe
        • 6.2.1. Europe Extracorporeal Membrane Oxygenation System Market: Regional Trend Analysis
          • 6.2.1.1. Germany
          • 6.2.1.2. France
          • 6.2.1.3. UK
          • 6.2.1.4. Russia
          • 6.2.1.5. Italy
          • 6.2.1.6. Spain
          • 6.2.1.7. Rest of Europe
      • 6.3. Asia-Pacific
        • 6.3.1. Asia-Pacific Extracorporeal Membrane Oxygenation System Market: Regional Trend Analysis
          • 6.3.1.1. China
          • 6.3.1.2. Japan
          • 6.3.1.3. Korea
          • 6.3.1.4. India
          • 6.3.1.5. Rest of Asia-Pacific
      • 6.4. Latin America
        • 6.4.1. Latin America Extracorporeal Membrane Oxygenation System Market: Regional Trend Analysis
          • 6.4.1.1. Brazil
          • 6.4.1.2. Argentina
          • 6.4.1.3. Rest of Latin America
      • 6.5. Middle East and Africa
        • 6.5.1. Middle East and Africa Extracorporeal Membrane Oxygenation System Market: Regional Trend Analysis
          • 6.5.1.1. GCC
          • 6.5.1.2. South Africa
          • 6.5.1.3. Israel
          • 6.5.1.4. Rest of MEA
    • 7. Global Extracorporeal Membrane Oxygenation System Market Competitive Landscape, Market Share Analysis, and Company Profiles
      • 7.1. Market Share Analysis
      • 7.2. Company Profiles
      • 7.3. Getinge Group
        • 7.3.1. Company Overview
        • 7.3.2. Financial Highlights
        • 7.3.3. Product Portfolio
        • 7.3.4. SWOT Analysis
        • 7.3.5. Key Strategies and Developments
      • 7.4. Medtronic plc
        • 7.4.1. Company Overview
        • 7.4.2. Financial Highlights
        • 7.4.3. Product Portfolio
        • 7.4.4. SWOT Analysis
        • 7.4.5. Key Strategies and Developments
      • 7.5. LivaNova PLC
        • 7.5.1. Company Overview
        • 7.5.2. Financial Highlights
        • 7.5.3. Product Portfolio
        • 7.5.4. SWOT Analysis
        • 7.5.5. Key Strategies and Developments
      • 7.6. XENIOS AG
        • 7.6.1. Company Overview
        • 7.6.2. Financial Highlights
        • 7.6.3. Product Portfolio
        • 7.6.4. SWOT Analysis
        • 7.6.5. Key Strategies and Developments
      • 7.7. Terumo Corporation
        • 7.7.1. Company Overview
        • 7.7.2. Financial Highlights
        • 7.7.3. Product Portfolio
        • 7.7.4. SWOT Analysis
        • 7.7.5. Key Strategies and Developments
      • 7.8. MicroPort Scientific Corporation
        • 7.8.1. Company Overview
        • 7.8.2. Financial Highlights
        • 7.8.3. Product Portfolio
        • 7.8.4. SWOT Analysis
        • 7.8.5. Key Strategies and Developments
      • 7.9. NIPRO Corporation
        • 7.9.1. Company Overview
        • 7.9.2. Financial Highlights
        • 7.9.3. Product Portfolio
        • 7.9.4. SWOT Analysis
        • 7.9.5. Key Strategies and Developments
      • 7.10. OriGen Biomedical
        • 7.10.1. Company Overview
        • 7.10.2. Financial Highlights
        • 7.10.3. Product Portfolio
        • 7.10.4. SWOT Analysis
        • 7.10.5. Key Strategies and Developments
      • 7.11. ALung Technologies
        • 7.11.1. Company Overview
        • 7.11.2. Financial Highlights
        • 7.11.3. Product Portfolio
        • 7.11.4. SWOT Analysis
        • 7.11.5. Key Strategies and Developments
      • 7.12. EUROSETS S.r.l.
        • 7.12.1. Company Overview
        • 7.12.2. Financial Highlights
        • 7.12.3. Product Portfolio
        • 7.12.4. SWOT Analysis
        • 7.12.5. Key Strategies and Developments
    • 8. Assumptions and Acronyms
    • 9. Research Methodology
    • 10. Contact
  • ondemand_videoVideos
    • 62796
    • US $6,000
      US $3,999
    • US $8,000
      US $5,999
    • US $10,000
      US $6,999
    Buy Now
    • Getinge Group
    • Medtronic plc
    • LivaNova PLC
    • XENIOS AG
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • NIPRO Corporation
    • OriGen Biomedical
    • ALung Technologies
    • EUROSETS S.r.l.
  • settingsSettings

Our Clients

Request for Sample


  • 62796
  • US $6,000
    US $3,999
  • US $8,000
    US $5,999
  • US $10,000
    US $6,999
Buy Now

Find Help

Legal

Explore

Secured Payment Options